“First Female Action Star”, Pam Grier, 74, Beat Stage 4 Cancer– Her New Honors & Impact

“She has blazed a trail for so many Black women in cinema and has left an indelible mark not only in the Blaxploitation genre but on the film industry,” said Fabienne Colas, the President and Founder of the Toronto Black Film Festival.

“Hailed as the Queen of Blaxploitation and the first female action hero, Pam Grier is a consummate screen actress who has helped to spark not one but multiple eras in American Black cinema. Her incendiary performances in iconic roles came at pivotal moments in the industry for both Black representation and representation of women on screen,” Colas continued.

Grier’s more notable roles include “Miami Vice,” “Coffy,” “Jackie Brown,” “Ghost of Mars,” and “Foxy Brown.”

Renowned civil rights attorney Ben Crump dedicated a social media post drawing added attention to the award-winning actress.

“Her roles playing strong Black female characters in the 70s paved the way for Black actresses today!” Crump said in an X post.

Grier’s ‘Two-Inch Thick Folder

More than a decade after infiltrating Hollywood, once the 1980s rolled around, Grier was forced to deal with a setback when she was diagnosed with cervical cancer. This type of cancer begins in the cells lining the cervix, the lower part of the womb (uterus). Treatment options for cervical cancer include surgery, chemotherapy, and radiation therapy.

Before her diagnosis, Grier was considered to be highly health conscious, running roughly “six miles a day, not eating meat and not abusing her body,” the Guardian reports.

However, a routine pap smear for cervical cancer discovered that she had “abnormal cells,” and the next day, her doctor told her that she only had “18 months to live.”

“They could operate or start treatment for another six weeks, as I’d already had surgery and my body had gone through so much trauma. I was told to start preparing for treatment and to organize my will. I coped from minute to minute. I went home to ponder this two-inch thick folder they give you,” Grier said.

She described her treatment as a “full-time job,” which included chemotherapy.

“In 1988, the C-word meant: ‘Oh my God, you’re going to die. There is no hope. ‘You learn who your friends are when you have cancer.”

Thankfully, Grier’s treatment worked, and she was able to reach remission and continues to thrive 36 years after her stage 4 diagnosis. She considers herself lucky.

Finding Hope and Inspiration to Help You Cope with Cervical Cancer

Cervical cancer forms in the cells of the cervix, the lower, narrow end of the uterus (womb), which connects the uterus to the vagina, according to the National Cancer Institute (NCI).

“Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which abnormal cells begin to appear in the cervical tissue,” the NCI explains.

“Over time, if not destroyed or removed, the abnormal cells may become cancer cells and start to grow and spread more deeply into the cervix and surrounding areas.”

While symptoms tend to be difficult to detect during cervical cancer’s early stages, some signs can still indicate something is amiss and needs a closer look.

The NCI explains that symptoms of early-stage cervical cancer may include:

• vaginal bleeding after sex
• vaginal bleeding after menopause
• vaginal bleeding between periods or periods that are heavier or longer than normal
• vaginal discharge that is watery and has a strong odor or that contains blood
• pelvic pain or pain during sex

Cervical Cancer Prevention

As noted, a pap smear is an option to detect cervical cancer early. During the test, a doctor will collect a sample of cells from your cervix (using a small brush or spatula). The cells are then examined under a microscope for abnormalities, including cancer and changes that could indicate pre-cancer.

The added value of pap smears is that symptoms of cervical cancer might show up until the disease is at stage 3 or 4 and more challenging to treat. This critical procedure helps doctors catch signs of the disease early. Furthermore, pap smears can lead to broader and more effective treatment options.

One of the leading causes of cervical cancer is the human papillomavirus (HPV).

The human papillomavirus (HPV) is “a group of more than 200 related viruses, some of which are spread through vaginal, anal or oral sex,” the National Cancer Institute says. HPV infection is linked to multiple cancers, and the majority of sexually active people will get the disease at some point in their lives.

A study presented during last year’s American Association for Cancer Research (AACR) 2023 annual meeting found that public awareness of the link between HPV and cervical cancer was on the decline.

“The important thing to know about HPV is that there are many different strains, and only a couple of them tend to be more cancer-inducing,” Dr. Allen Ho, a head and neck surgeon at Cedars-Sinai, told SurvivorNet.

“Probably less than 1% of the population who get infected happen to have the cancer-causing virus that somehow their immune system fails to clear, and over 15 to 20 years [it] develops from a viral infection into a tumor, and cancer,” Dr. Ho added.

Protecting Against HPV

The HPV vaccine is recommended to protect against HPV and, therefore, HPV-related cancers.

Gardasil 9 is an HPV vaccine that offers protection against “nine HPV types: the two low-risk HPV types that cause most genital warts, plus seven high-risk HPV types that cause most HPV-related cancer,” according to the National Cancer Institute.

The vaccine creates an immune response to HPV 16, the primary cause of 92% of head and neck cancers. Once children are vaccinated, they cannot be infected with that strain. For parents, the HPV vaccine enables them to protect their children from developing cancer in the future.

“The key with the vaccine is that you receive it before you have sexual encounters,” says Dr. Geiger. “So that’s why these vaccines are approved for young children … ages 9, 10, 11 years old, up to age 26.”

The HPV vaccine is recommended for all male and female preteens 11 to 12 years old in two doses given between six and 12 months, according to the CDC.

The series of shots can also start as young as nine.

The CDC also notes that teens and young adults through age 26 who didn’t start or finish the HPV vaccine series also need the vaccine.

Additionally, people with weakened immune systems or teens and young adults between 15 and 26 who started the series should get three doses instead of two.

Although adults up to 45 can still receive the vaccine, it’s not recommended for everyone older than 26. Still, a person older than 26 could choose to get vaccinated after talking to their doctor about possible benefits, even despite it being less effective in this age range, as more people have already been exposed to HPV by this point.

WATCH: Should children get the HPV Vaccine?

Vaccine hesitancy can impede people from getting the vaccine. The concern may come from parents who may feel the vaccine paves the way for early sexual activity. For this reason, some health practitioners are educating the public about the vaccine differently.

“I think rebranding the vaccine as a cancer vaccine, rather than an STD vaccine, is critically important,” says Dr. Ted Teknos, a head and neck cancer surgeon and scientific director of University Hospital’s Seidman Cancer Center.

Dr. Teknos believes concerted efforts to “change the mindset around the vaccine” can make a difference.

Learn more about SurvivorNet's rigorous medical review process.

---